CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 375371-375653 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T3103","span":{"begin":0,"end":282},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The VP assay on ARIES is easy to perform and has better sensitivity compared to currently widely used BD Affirm with ability of also discriminating between Candida species. typically receive empirical treatment with broad-spectrum agents, which are inadequate in up to 30% of cases."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T100","span":{"begin":0,"end":282},"obj":"Sentence"}],"text":"The VP assay on ARIES is easy to perform and has better sensitivity compared to currently widely used BD Affirm with ability of also discriminating between Candida species. typically receive empirical treatment with broad-spectrum agents, which are inadequate in up to 30% of cases."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2055","span":{"begin":4,"end":6},"obj":"Disease"},{"id":"T2056","span":{"begin":102,"end":104},"obj":"Disease"},{"id":"T5496","span":{"begin":4,"end":6},"obj":"Disease"},{"id":"T63407","span":{"begin":102,"end":104},"obj":"Disease"}],"attributes":[{"id":"A2055","pred":"mondo_id","subj":"T2055","obj":"http://purl.obolibrary.org/obo/MONDO_0008297"},{"id":"A2056","pred":"mondo_id","subj":"T2056","obj":"http://purl.obolibrary.org/obo/MONDO_0007191"},{"id":"A81453","pred":"mondo_id","subj":"T5496","obj":"http://purl.obolibrary.org/obo/MONDO_0008297"},{"id":"A75712","pred":"mondo_id","subj":"T63407","obj":"http://purl.obolibrary.org/obo/MONDO_0007191"}],"text":"The VP assay on ARIES is easy to perform and has better sensitivity compared to currently widely used BD Affirm with ability of also discriminating between Candida species. typically receive empirical treatment with broad-spectrum agents, which are inadequate in up to 30% of cases."}